PubRank
Search
About
Heather A Lankes
Author PubWeight™ 13.83
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Selumetinib in women with recurrent low-grade serous carcinoma of the ovary or peritoneum: an open-label, single-arm, phase 2 study.
Lancet Oncol
2012
2.14
2
Activity of sorafenib in recurrent ovarian cancer and primary peritoneal carcinomatosis: a gynecologic oncology group trial.
J Clin Oncol
2010
1.26
3
A phase II evaluation of aflibercept in the treatment of recurrent or persistent endometrial cancer: a Gynecologic Oncology Group study.
Gynecol Oncol
2012
0.97
4
Lapatinib and potential prognostic value of EGFR mutations in a Gynecologic Oncology Group phase II trial of persistent or recurrent endometrial cancer.
Gynecol Oncol
2012
0.97
5
Ductal lavage is an inefficient method of biomarker measurement in high-risk women.
Cancer Prev Res (Phila)
2009
0.95
6
Reproducibility of ductal lavage cytology and cellularity over a six month interval in high risk women.
Breast Cancer Res Treat
2007
0.95
7
A phase II evaluation of lapatinib in the treatment of persistent or recurrent epithelial ovarian or primary peritoneal carcinoma: a gynecologic oncology group study.
Gynecol Oncol
2011
0.91
8
Phase II evaluation of dasatinib in the treatment of recurrent or persistent epithelial ovarian or primary peritoneal carcinoma: a Gynecologic Oncology Group study.
Gynecol Oncol
2012
0.88
9
A simple method for displaying recalcitrant proteins on the surface of bacteriophage lambda.
Nucleic Acids Res
2005
0.88
10
Phase II study of cisplatin plus cetuximab in advanced, recurrent, and previously treated cancers of the cervix and evaluation of epidermal growth factor receptor immunohistochemical expression: a Gynecologic Oncology Group study.
Gynecol Oncol
2011
0.85
11
Human papillomavirus-like particles mediate functional delivery of plasmid DNA to antigen presenting cells in vivo.
Vaccine
2007
0.82
12
Expression Patterns of the Wnt Pathway Inhibitors Dickkopf3 and Secreted Frizzled-Related Proteins 1 and 4 in Endometrial Endometrioid Adenocarcinoma: An NRG Oncology/Gynecologic Oncology Group Study.
Int J Gynecol Cancer
2016
0.79
13
A phase II study of a urokinase-derived peptide (A6) in the treatment of persistent or recurrent epithelial ovarian, fallopian tube, or primary peritoneal carcinoma: a Gynecologic Oncology Group study.
Gynecol Oncol
2012
0.79
14
A modified Latent Class Model assessment of human papillomavirus-based screening tests for cervical lesions in women with atypical glandular cells: a Gynecologic Oncology Group study.
Cancer Causes Control
2012
0.77